Lymphoma News
June 25, 2025
Top Headlines
June 20, 2025 Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response with just one dose. By combining two immune-boosting adjuvants alum and SMNP the vaccine lingers in lymph nodes for nearly ...
May 16, 2025 A new gene editor may soon open the door to gene therapies for a wider array of ...
May 16, 2025 Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of non-Hodgkin's lymphomas and is a rare but aggressive form ...
May 15, 2025 Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, stroke or heart attack, a new study shows. The finding might help clinicians ...
May 8, 2025 A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory ...
May 4, 2025 Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting ...
May 4, 2025 Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat ...
May 1, 2025 A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved a 100% overall response rate and a 50% complete remission rate, in ...
Apr. 29, 2025 Scientists have uncovered why vaccines can elicit a stronger immune response if they are administered in the same ...
Apr. 22, 2025 Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of the immune system, which then go to work to clear ...
Apr. 4, 2025 A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
Mar. 19, 2025 A study has shown that lymph node transfer is a viable treatment for the swelling in the affected limb, a condition known as lymphedema, after breast cancer surgery. However, an effective drug to improve the outcomes of the transfer treatment ...
Latest Headlines
updated 11:44am EDT
Mar. 25, 2025 Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies. Many ...
Mar. 4, 2025 Research has shown that tattoo ink does not just remain where it is injected. Particles from the ink can migrate to the lymph nodes, where they ...
Feb. 16, 2025 When a tumour develops, it creates a structure around itself called the tumour stroma, within which blood and lymphatic vessels ensure nutritional and respiratory biological exchanges. ...
Feb. 14, 2025 Researchers have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...
Feb. 14, 2025 A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest ...
Jan. 23, 2025 Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...
Jan. 11, 2025 A look at cancer cells: Thanks to an innovative method of super-resolution microscopy, researchers observed with molecular resolution in 3D how therapeutic antibodies attack and alter B cells, ...
Dec. 9, 2024 An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer ...
Dec. 5, 2024 Researchers have found a new receptor for nerve growth factor that plays an important role in pain signaling, even though it does not signal on its ...
Nov. 13, 2024 Why do some people develop severe flu symptoms? A study points the finger at an unsung portion of the antibodies our immune systems generate to fend ...
Earlier Headlines
Oct. 31, 2024 With the goals of informing surgical management, improving long-term outcomes and lowering death rates of patients with testicular cancer, a study has found that the conventional, versatile open ...
Oct. 23, 2024 Researchers have reduced scar formation and improved heart function in mouse models of heart failure using a monoclonal antibody treatment, similar to that approved by the FDA to treat other ...
Oct. 17, 2024 Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen. This is compared to 83% ...
Sep. 26, 2024 Research has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections. Using genetic and functional approaches, the researchers ...
Sep. 20, 2024 Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week ...
Sep. 16, 2024 Monoclonal antibodies -- treatments developed by cloning a cell that makes an antibody -- could help provide an answer to the growing problem of antimicrobial resistance, say ...
Aug. 20, 2024 Scientists have discovered why the flu vaccine can perform poorly. They found that a specific type of immune cell, called T follicular helper cells, indirectly controls the anti-influenza response. ...
Aug. 9, 2024 A 'loopy' discovery in bacteria is raising fundamental questions about the makeup of our own genome -- and revealing a potential wellspring of material for new genetic ...
July 22, 2024 Scientists have discovered a way to turn the body's B cells into tiny surveillance machines and antibody factories that can pump out specially designed antibodies to destroy cancer cells or HIV, ...
July 22, 2024 The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a protein found ...
June 20, 2024 Research scientists found that a 'one-two punch' of combining the immunosuppressive drug ruxolitinib with existing checkpoint inhibitor therapies may be a more effective way to fight some ...
June 19, 2024 Recently, scientists found that some people who suffered from COVID-19 had auto-antibodies targeting their own type 1 interferons, which are important immune signaling proteins. Now, researchers ...
June 12, 2024 CAR-T cell therapies are transforming the treatment of previously incurable blood cancers, but a large proportion of patients still responds only poorly or not at all to them, calling for new ...
June 6, 2024 Scientists say they have developed an artificial lymph node with the potential to treat cancer, according to a new study in mice and human ...
May 30, 2024 A new human monoclonal antibody moves a step closer to a universal antibody cocktail that works against all strains of ...
May 17, 2024 A study has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes ...
May 6, 2024 Researchers have found a way to enhance and extend LN expansion, and study how this phenomenon affects both the immune system and efficacy of vaccinations against tumors. While the oversized LNs ...
Apr. 17, 2024 Investigators have discovered how brain cells responsible for working memory -- the type required to remember a phone number long enough to dial it -- coordinate intentional focus and short-term ...
Apr. 4, 2024 It is possible to leave most of the lymph nodes in the armpit, even if one or two of them have metastases larger than two millimeters. This is shown in a trial enrolling women from five countries. ...
Apr. 2, 2024 A novel treatment for leukemias and lymphomas that arise from immune system T cells was found to be effective at killing these cancers in mice bearing human T-cell ...
Thursday, October 31, 2024
Wednesday, October 23, 2024
Thursday, October 17, 2024
Thursday, September 26, 2024
Friday, September 20, 2024
Monday, September 16, 2024
Tuesday, August 20, 2024
Friday, August 9, 2024
Monday, July 22, 2024
- B Cell Biohack: Immune Cells to Churn out Custom Antibodies
- Knockout of CD5 on CAR T Cells Boosts Anti-Tumor Efficacy
Thursday, June 20, 2024
Wednesday, June 19, 2024
Wednesday, June 12, 2024
Thursday, June 6, 2024
Thursday, May 30, 2024
Friday, May 17, 2024
Monday, May 6, 2024
Wednesday, April 17, 2024
Thursday, April 4, 2024
Tuesday, April 2, 2024
Tuesday, March 12, 2024
Wednesday, February 14, 2024
Friday, January 26, 2024
Wednesday, January 24, 2024
Wednesday, January 17, 2024
Monday, December 11, 2023
Thursday, November 16, 2023
Wednesday, November 15, 2023
Thursday, November 9, 2023
Monday, November 6, 2023
Friday, November 3, 2023
Thursday, November 2, 2023
Wednesday, September 13, 2023
Monday, September 11, 2023
Friday, September 1, 2023
Thursday, August 31, 2023
Thursday, August 17, 2023
Tuesday, August 8, 2023
Tuesday, July 18, 2023
Thursday, May 25, 2023
Monday, March 20, 2023
Thursday, March 2, 2023
Tuesday, February 21, 2023
Tuesday, February 14, 2023
Monday, February 13, 2023
Wednesday, February 1, 2023
Tuesday, January 24, 2023
Monday, January 9, 2023
Thursday, December 22, 2022
Wednesday, December 21, 2022
Tuesday, December 20, 2022
- First-Line Immune Defenses Against COVID-19 Are Short-Lived and May Explain Reinfection, Study Shows
Monday, December 12, 2022
Tuesday, December 6, 2022
Wednesday, November 30, 2022
Tuesday, November 22, 2022
Thursday, November 17, 2022
Wednesday, November 16, 2022
Wednesday, November 9, 2022
Tuesday, November 8, 2022
Tuesday, November 1, 2022
Wednesday, October 26, 2022
- New Lassa Fever Therapy May Be on the Horizon
- Antibody Blunts Heroin's Lethality, Paving the Way for a Promising New Therapy